MoneyWorks4Me

Medicamen Biotech - Quaterly Results

10 Feb 2023 Evaluate
The total revenue for the quarter ended December 2022 remained nearly unchanged at Rs. 341.16 millions.A slender decline of -0.48% was recorded to Rs. 37.60  millions from Rs. 37.78 millions in the corresponding previous quarter.Operating Profit reported a sharp decline to 64.95 millions from 71.36 millions in the corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 341.16 326.41 4.52 1007.36 926.91 8.68 1154.45 1101.46 4.81
Other Income 6.29 8.27 -23.94 21.16 13.82 53.11 17.20 7.54 128.12
PBIDT 64.95 71.36 -8.98 194.94 199.58 -2.32 252.74 203.35 24.29
Interest 6.82 4.93 38.34 20.65 8.37 146.71 14.01 10.64 31.67
PBDT 58.13 66.43 -12.49 174.29 191.21 -8.85 238.73 192.71 23.88
Depreciation 16.01 15.67 2.17 47.43 42.47 11.68 57.71 25.20 129.01
PBT 42.12 50.76 -17.02 126.86 148.74 -14.71 181.02 167.51 8.07
TAX 4.52 12.98 -65.18 17.29 27.23 -36.50 31.97 42.65 -25.04
Deferred Tax -3.32 -2.54 30.71 -8.95 -7.19 24.48 -7.80 1.19 -755.46
PAT 37.60 37.78 -0.48 109.57 121.51 -9.83 149.05 124.86 19.37
Equity 126.51 122.17 3.55 126.51 122.17 3.55 122.17 122.17 0.00
PBIDTM(%) 19.04 21.86 -12.92 19.35 21.53 -10.13 21.89 18.46 18.58
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..